List of Major Stock Market Sectors
Stock of the day
Celladon (CLDN) Stock Pummeled After Negative Trial Results, Downgrade
Shares of Celladon Corp. (CLDN) were down -10.10 or -73.83 percent to $3.56 per share in Monday's premarket, after news over the weekend that the company's drug for advanced heart failure had failed to meet primary and secondary endpoints in trials. In addition, due to the news, the stock was downgraded significantly by an analyst. ... READ MORE
Read the rest of Celladon (CLDN) Stock Pummeled After Negative Trial Results, Downgrade at InvestorGuide.com.Read More
Click here to see the complete Stock of the Day archives!
On This Date
The AT&T Wireless IPO raises $10.6 billion in the largest U.S. IPO in history.